{"id":"https://openalex.org/W129079388","doi":null,"title":"Disease progression and the need for neuroprotection in glaucoma management.","display_name":"Disease progression and the need for neuroprotection in glaucoma management.","publication_year":2008,"publication_date":"2008-02-01","ids":{"openalex":"https://openalex.org/W129079388","mag":"129079388","pmid":"https://pubmed.ncbi.nlm.nih.gov/18284311"},"language":"en","primary_location":{"id":"pmid:18284311","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18284311","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046921541","display_name":"Rohit Varma","orcid":"https://orcid.org/0000-0002-9224-2909","observed_orcids":["https://orcid.org/0000-0002-9224-2909"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rohit Varma","raw_affiliation_strings":["University of Southern California, 1450 San Pablo St, Room 4900, Los Angeles, CA 90033, USA. rvarma@hsc.usc.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southern California, 1450 San Pablo St, Room 4900, Los Angeles, CA 90033, USA. rvarma@hsc.usc.edu","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071188023","display_name":"Patti Peeples","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patti Peeples","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103579509","display_name":"John G. Walt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John G Walt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5079067628","display_name":"Thomas J. Bramley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas J Bramley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.997,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.92457581,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"14","issue":"1 Suppl","first_page":"S15","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glaucoma","display_name":"glaucoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.7580000162124634},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.996999979019165},{"id":"https://openalex.org/keywords/retinal-ganglion-cell-loss","display_name":"retinal ganglion cell death","score":0.9070000052452087},{"id":"https://openalex.org/keywords/optic-neuropathy","display_name":"optic neuropathy","score":0.8820000290870667},{"id":"https://openalex.org/keywords/intraocular-pressure","display_name":"intraocular pressure","score":0.7699999809265137},{"id":"https://openalex.org/keywords/glaucoma-treatment","display_name":"glaucoma treatment","score":0.6290000081062317},{"id":"https://openalex.org/keywords/visual-field-defects","display_name":"visual field defects","score":0.671999990940094},{"id":"https://openalex.org/keywords/optic-disc-damage","display_name":"optic disc damage","score":0.578000009059906},{"id":"https://openalex.org/keywords/blindness-prevention","display_name":"blindness prevention","score":0.6859999895095825}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9313076138496399},{"id":"https://openalex.org/C2778527774","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Glaucoma","level":2,"score":0.8738573789596558},{"id":"https://openalex.org/C2778233873","wikidata":"https://www.wikidata.org/wiki/Q2879095","display_name":"Optic neuropathy","level":3,"score":0.6137107610702515},{"id":"https://openalex.org/C2780837183","wikidata":"https://www.wikidata.org/wiki/Q186029","display_name":"Optic nerve","level":2,"score":0.6001222133636475},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.5875914096832275},{"id":"https://openalex.org/C2781092963","wikidata":"https://www.wikidata.org/wiki/Q650050","display_name":"Intraocular pressure","level":2,"score":0.5495891571044922},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5241553783416748},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.49872589111328125},{"id":"https://openalex.org/C2777624874","wikidata":"https://www.wikidata.org/wiki/Q927337","display_name":"Retinal ganglion cell","level":3,"score":0.4497591257095337},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.4486331641674042},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.33682382106781006},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2058911919593811}],"mesh":[{"descriptor_ui":"D001766","descriptor_name":"Blindness","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005901","descriptor_name":"Glaucoma","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D005901","descriptor_name":"Glaucoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005901","descriptor_name":"Glaucoma","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D005901","descriptor_name":"Glaucoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009901","descriptor_name":"Optic Nerve Diseases","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009901","descriptor_name":"Optic Nerve Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009901","descriptor_name":"Optic Nerve Diseases","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D009901","descriptor_name":"Optic Nerve Diseases","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D012165","descriptor_name":"Retinal Ganglion Cells","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019636","descriptor_name":"Neurodegenerative Diseases","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D019636","descriptor_name":"Neurodegenerative Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D019636","descriptor_name":"Neurodegenerative Diseases","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D019636","descriptor_name":"Neurodegenerative Diseases","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:18284311","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18284311","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Journal Article"},{"id":"mag:129079388","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18284311","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2158521222","https://openalex.org/W2016869604","https://openalex.org/W2009412770","https://openalex.org/W1552609401","https://openalex.org/W2788179764","https://openalex.org/W2188059801","https://openalex.org/W67231565","https://openalex.org/W1996615611","https://openalex.org/W1542770233","https://openalex.org/W4362663178"],"abstract_inverted_index":{"Glaucoma,":[0],"the":[1,40,83,95,132,136],"second":[2],"leading":[3],"cause":[4,140],"of":[5,17,43,61,74,85,116,156],"worldwide":[6],"blindness,":[7],"is":[8,30,46,68],"a":[9,15,71,107,111,118],"progressive":[10],"optic":[11,33,133],"neuropathy":[12],"characterized":[13],"by":[14,32,121],"loss":[16],"retinal":[18,87],"ganglion":[19,88],"cells":[20],"and":[21,35,39,56,105,143,153,159,167],"their":[22],"axons":[23],"beyond":[24],"typical":[25],"age-related":[26],"baseline":[27],"loss.":[28],"Diagnosis":[29],"defined":[31],"disc":[34],"visual":[36],"field":[37],"changes,":[38],"primary":[41],"goal":[42,84],"glaucoma":[44,141],"treatment":[45,100],"to":[47],"preserve":[48,131],"vision.":[49],"Proven":[50],"existing":[51],"therapies":[52],"(ie,":[53],"pharmacotherapy,":[54],"laser,":[55],"surgical)":[57],"focus":[58],"on":[59],"reduction":[60],"intraocular":[62],"pressure":[63],"(IOP),":[64],"although":[65],"elevated":[66],"IOP":[67],"no":[69],"longer":[70],"diagnostic":[72],"feature":[73],"glaucoma.":[75],"New":[76],"neuroprotectant":[77,108,119,160],"drugs":[78],"are":[79,102],"being":[80,103],"investigated,":[81],"with":[82],"reducing":[86],"cell":[89],"loss,":[90],"either":[91],"prophylactically":[92],"or":[93,110],"after":[94],"insult":[96],"has":[97],"occurred.":[98],"Various":[99],"strategies":[101],"evaluated,":[104],"include":[106,151],"only,":[109],"complete":[112,127],"therapy":[113,128,148],"approach":[114],"comprised":[115],"both":[117],"supplemented":[120],"an":[122],"IOP-lowering":[123],"therapy.":[124],"Dually":[125],"targeted":[126],"may":[129],"directly":[130],"nerve,":[134],"decrease":[135],"risk":[137],"factors":[138],"that":[139],"damage,":[142],"reduce":[144],"glaucoma-related":[145],"morbidities.":[146],"Neuroprotectant":[147],"outcomes":[149],"should":[150],"functional":[152],"structural":[154],"effects":[155],"disease":[157],"progression":[158],"therapies,":[161],"as":[162,164],"well":[163],"patient":[165],"functioning":[166],"economic":[168],"impact.":[169]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}